SCHEMBL16851069

SCHEMBL16851069

CCCCCCCCCc1c(C(=O)OCC)c(C)nc(C)c1C(=O)OCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
NPSR1 Q6W5P4 4/20 0.49
KDM4E B2RXH2 3/20 0.49
GAA P10253 3/20 0.49
ALDH1A1 P00352 3/20 0.49
RAB9A P51151 2/20 0.49
MAPT P10636 2/20 0.49
NPC1 O15118 1/20 0.49
HPGD P15428 1/20 0.49
ADORA3 P0DMS8 4/20 0.47
PKM P14618 1/20 0.47
HTT P42858 1/20 0.47
POLB P06746 2/20 0.46
PDE4D Q08499 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
TP53 P04637 2/20 0.43
HSD17B10 Q99714 2/20 0.43
MAPK1 P28482 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16851076 1.00 LMNA (0.49) LMNASMN1; SMN2NPSR1KDM4EGAA
SCHEMBL16851080 0.93 GAA (0.51) LMNASMN1; SMN2NPSR1KDM4EGAA
SCHEMBL16851072 0.88 ADORA3 (0.53) LMNASMN1; SMN2NPSR1KDM4EGAA
SCHEMBL6324695 0.83 GAA (0.39) LMNASMN1; SMN2NPSR1KDM4EGAA
SCHEMBL16851079 0.80 ADORA3 (0.65) LMNASMN1; SMN2NPSR1KDM4EGAA
SCHEMBL27708851 0.77 NPSR1 (0.38) LMNASMN1; SMN2NPSR1KDM4EGAA
SCHEMBL28646839 0.77 NR1H2 (0.59) SMN1; SMN2KDM4EHPGDUSP2CYP3A4
SCHEMBL22192888 0.76 ADORA3 (0.63) LMNASMN1; SMN2NPSR1KDM4EGAA
SCHEMBL28548859 0.75 SMN1; SMN2 (0.40) LMNASMN1; SMN2NPSR1KDM4EGAA
SCHEMBL16851073 0.75 ALDH1A1 (0.50) LMNASMN1; SMN2NPSR1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11731117-B2 Compositions of certain manganese accumulating plants CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-08-22 US disclosed
US-20150174566-A1 USE OF CERTAIN MANGANESE-ACCUMULATING PLANTS FOR CARRYING OUT ORGANIC CHEMISTRY REACTIONS UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES (FR) 2015-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11731117-B2 Compositions of certain manganese accumulating plants AS3MT, ME3, CACYBP LMNA 1950/4885SMN1; SMN2 525/4885NPSR1 4647/4885
US-20150174566-A1 USE OF CERTAIN MANGANESE-ACCUMULATING PLANTS FOR CARRYING OUT ORGANIC CHEMISTRY REACTIONS OAT, ME1, ME3 LMNA 3172/4885SMN1; SMN2 2410/4885NPSR1 3915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.